THE WORLD'S LEADING PROVIDER
OF ORALLY ADMINISTERED, SMALL-MOLECULE
DRUGS THAT TREAT DISEASES BY
TARGETING AND MODULATING RNA.
JUPITER, FL, April 30, 2013 – SMaRT Therapeutics, Inc., a leading biotechnology company focused on the development of small-molecule drugs that target and modulate RNA, announced the appointment of Dr. John H. Abeles to its Advisory Board.
JUPITER, FL, December 20, 2012 - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.
JUPITER, FL, November 9, 2012 – Two chemists from the Florida campus of The Scripps Research Institute (TSRI) have been selected by the American Chemical Society (ACS) to receive a pair of prestigious awards honoring early-career research in biological and enzyme chemistry. Associate Professors Matthew Disney, PhD, and Kate Carroll, PhD, w ill be recognized at the fall 2013 ACS symposium, to be held in Indianapolis.